American Alpha Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$733K Buy
5,707
+66
+1% +$7.72K 0.4% 43
2026
Q1
$679K Sell
5,641
-411
-7% -$47.5K 0.36% 47
2025
Q4
$637K Buy
6,052
+766
+14% +$71.9K 0.38% 46
2025
Q3
$444K Sell
5,286
-305
-5% -$25.1K 0.31% 55
2025
Q2
$443K Buy
5,591
+913
+20% +$72.6K 0.35% 53
2025
Q1
$420K Buy
+4,678
New +$437K 0.35% 55

Other funds holding MRK

American Alpha Advisors's MRK Position: Q2 2026 in Review

American Alpha Advisors increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $7.72K and bringing the position to 5,707 shares worth $733K. The position accounts for 0.4% of the portfolio, ranked #43.

American Alpha Advisors first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • American Alpha Advisors held 5,707 shares of Merck worth $733K as of Q2 2026.
  • American Alpha Advisors bought 66 Merck shares in Q2 2026, an estimated $7.72K.
  • Merck made up 0.4% of American Alpha Advisors's portfolio in Q2 2026, its #43 holding.
  • American Alpha Advisors first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on American Alpha Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.